FindTrial
Sign In

Insulin Monotherapy for Very Severe Hypertriglyceridemia Induced Acute Pancreatitis: A Randomized Controlled Trial

Insulin Monotherapy for Very Severe Hypertriglyceridemia Induced Acute Pancreatitis: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114270
Enrollment
Unknown
Registered
2025-12-09
Start date
2025-12-31
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemic induced acute pancreatitis

Interventions

Insulin pump monotherapy group:Insulin pump monotherapy
Insulin pump with LWMH group:Insulin pump combined with low molecular weight heparin

Sponsors

The First Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-80 years old. (2) Diagnosed with HTG-AP (extremely severe hypertriglyceridemia-induced acute pancreatitis).

Exclusion criteria

Exclusion criteria: (1) VTE (Padua score) >= 4 points; (2) Coexisting malignant tumor; (3) Previous pancreatic surgery; (4) History of previous digestive tract diseases; (5) Coexisting other major diseases such as heart, liver, lung and kidney; (6) Pregnancy or lactation period; (7) Mental illness that cannot cooperate.

Design outcomes

Primary

MeasureTime frame
Persistent organ failure;—

Secondary

MeasureTime frame
TG lowering efficacy;pancreatic necrosis;mortality;hospital length of stay;hospitalization cast;—

Countries

China

Contacts

Public ContactMeng Jin

The First Affiliated Hospital, School of Medicine, Zhejiang University

348808620@qq.com+86 188 1301 9371

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026